Article
Neurexins in autism and schizophrenia-a review of patient mutations, mouse models and potential future directions.
Molecular psychiatry - 1 Mar 2021
Tromp Alisha, Mowry Bryan, Giacomotto Jean
Abstract excerpt
Mutations in the family of neurexins (NRXN1, NRXN2 and NRXN3) have been repeatedly identified in patients with autism spectrum disorder (ASD) and schizophrenia (SCZ). However, it remains unclear how these DNA variants affect neurexin functions and thereby predispose to these neurodevelopmental disorders. Understanding both the wild-type and pathologic roles of these genes in the brain could help unveil biological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
